Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET
GW Sloof - Best Practice & Research Clinical Gastroenterology, 2006 - Elsevier
Neoadjuvant or adjuvant multimodality therapy in oesophageal cancer is introduced in an
effort to improve prognosis. However, in a substantial fraction of patients there is no
response to this non-surgical therapy. Non-invasive imaging modalities such as computed
tomography (CT), endoscopic ultrasound (EUS) and 18F-2-fluoro-2-deoxy-d-glucose
positron emission tomography (FDG-PET) have been evaluated for assessing patient
response to therapy, and these are described in this review. Currently, FDG-PET seems to …
effort to improve prognosis. However, in a substantial fraction of patients there is no
response to this non-surgical therapy. Non-invasive imaging modalities such as computed
tomography (CT), endoscopic ultrasound (EUS) and 18F-2-fluoro-2-deoxy-d-glucose
positron emission tomography (FDG-PET) have been evaluated for assessing patient
response to therapy, and these are described in this review. Currently, FDG-PET seems to …
以上显示的是最相近的搜索结果。 查看全部搜索结果